Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

LESCOL 20MG DIN 02061562

Status: Cancelled Post Market
Holder: NOVARTIS PHARMACEUTICALS CANADA INC
Molecule: FLUVASTATIN (FLUVASTATIN SODIUM)

Health Canada record

Active ingredient(s)FLUVASTATIN (FLUVASTATIN SODIUM) 20 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCC10AA04 FLUVASTATIN
Original market date31-Dec-1994
Current status date21-Sep-2018
SourceHealth Canada DPD

Establishment licence of the holder

Novartis Pharmaceuticals Canada Inc — licence 100273, currently licensed, last inspection rating C (2025-01-14).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing FLUVASTATIN (FLUVASTATIN SODIUM)

DINProductCompanyFormStrengthStatus
02299232TEVA-FLUVASTATINTEVA CANADA LIMITEDCapsuleFLUVASTATIN (FLUVASTATIN SODIUM) 40 MGMarketed
02299224TEVA-FLUVASTATINTEVA CANADA LIMITEDCapsuleFLUVASTATIN (FLUVASTATIN SODIUM) 20 MGMarketed
02061570LESCOL 40MGNOVARTIS PHARMACEUTICALS CANADA INCCapsuleFLUVASTATIN (FLUVASTATIN SODIUM) 40 MGCancelled Post Market
02250527LESCOL XLNOVARTIS PHARMACEUTICALS CANADA INCTablet (Extended-Release)FLUVASTATIN (FLUVASTATIN SODIUM) 80 MGCancelled Post Market
02400235SANDOZ FLUVASTATINSANDOZ CANADA INCORPORATEDCapsuleFLUVASTATIN (FLUVASTATIN SODIUM) 20 MGCancelled Post Market
02400243SANDOZ FLUVASTATINSANDOZ CANADA INCORPORATEDCapsuleFLUVASTATIN (FLUVASTATIN SODIUM) 40 MGCancelled Post Market
02492385SANDOZ FLUVASTATIN XLSANDOZ CANADA INCORPORATEDTablet (Extended-Release)FLUVASTATIN (FLUVASTATIN SODIUM) 80 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
38161997-08-13New Drug Submission (NDS)
Request a quote for LESCOL 20MG

How to read a Canadian DIN record